EN DE
Watch Canton Strategic Holdings, Inc. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Canton Strategic Holdings, Inc. (CNTN) fair value: what the stock is really worth

As of Oct 30, 2026: fair value (intrinsic value) of Canton Strategic Holdings, Inc. stock $0.47, price $1.95, upside -76.0%, quality 21 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US

CS Canton Strategic Holdings, Inc. logo Thin data Oct 30, 2026

Canton Strategic Holdings, Inc.

CNTN · US
Very expensive, weak quality

Our calculation puts a fair price 76% below what the stock costs today.

Fair value $0.4675 · Strongly overvalued (−76.0%)
Quality 21/100
Negative free cash flow
Trails peers (2/6)
Narrow moat 5/100 · thin data
Thin data
⚠ Dilution
Watch Canton Strategic Holdings, Inc. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$1,538 $1.05 Fair Value $0.4675 Jan 2022 Oct 2026

White line = price, green steps = our fair value per fiscal year. As of Oct 30, 2026.

How to read this chart

58‑month range $1.05 – $1,538 · fair‑value band $0.3910 – $0.5355 · the $1.95 price screens above the $0.4675 fair value. As of Oct 30, 2026.

Follow Canton Strategic Holdings in your weekly email

Every Wednesday you see whether Canton Strategic Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology.

Show moreShow less

The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management.

It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions.

The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.

Stock analysis

Canton Strategic Holdings, Inc. (CNTN) currently trades at $1.95, while our model-based Fair Value estimate is $0.4675, 76.0% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: $0.3910 (bear) to $0.5355 (bull), the price of $1.95 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 21/100 (below-average quality), in the Healthcare sector.

Canton Strategic Holdings, Inc. reported revenue of $0 in FY2025 versus $0 in FY2021. Reported net income was −$35.9M in FY2025.

Key figures

Market cap $163M Micro · EPS (TTM) $−0.1000 · Return on equity −42.2% · Return on assets (EBIT) −209% · Operating margin −80.4% · Revenue (TTM) $1.5M · Free cash flow −$16.1M · Net cash $17.0M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (low confidence).

What moves the price

The share trades about 64% below its 52-week high and 15% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at −76%, CNTN screens richer than that median.

Fair Value models

Bear $0.3910 Fair Value $0.4675 Bull $0.5355
Price $1.95 · Upside -76.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA $0.4600 $0.5500 $0.6300 64
All 1 models by family
Multiples
EV/EBITDA $0.4600 $0.5500 $0.6300 64

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 21/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 75
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 53
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 12
How calm the share price moves, does not count
Momentum 18
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 4
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

CNTN screens overvalued: fair value 76% below the price. Compare with Vertex Pharmaceuticals Incorporated →

Compare Canton Strategic Holdings, Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 588 stocks

Beats the industry median on 2/5 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 21 · Bottom 25%
Fair Value upside −77.2% · Bottom 25%
Profitability
Return on assets −6.9% · Above median
Operating margin (12 months) −80.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 0.0% · Above median

Valuation Multiplesvs Biotechnology median · lower = cheaper

P/B 0.41× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Biotechnology stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Incyte Corporation INCY $116.80 $203.62 +74% vs CNTN
Regeneron Pharmaceuticals, Inc REGN $818.77 $1,275 +56% vs CNTN
Vertex Pharmaceuticals Incorporated VRTX $540.00 $594.00 +10% vs CNTN
Samsung Biologics Co 207940 1,487,000 KRW 1,635,700 KRW +10% vs CNTN
WuXi Biologics (Cayman) Inc 2269 HK$45.06 HK$49.57 +10% vs CNTN
argenx SE ARGX $882.48 $908.40 +3% vs CNTN
CSL Limited CSL A$200.73 A$178.58 −11% vs CNTN
BeOne Medicines AG 6160 HK$217.60 HK$153.56 −29% vs CNTN
Celltrion, Inc 068270 189,300 KRW 74,945 KRW −60% vs CNTN
Royalty Pharma plc RPRX $64.76 $19.01 −71% vs CNTN

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Canton Strategic Holdings, Inc. · Fair Value
$0.4675 −76%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Canton Strategic Holdings, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/CNTN

Frequently asked questions

Is Canton Strategic Holdings, Inc. (CNTN) overvalued or undervalued?
As of Oct 30, 2026, our model estimates a fair value of $0.4675 versus a price of $1.95, about −76% upside (overvalued).
What is the fair value of CNTN?
Our model-based fair value for Canton Strategic Holdings, Inc. is $0.4675 (as of Oct 30, 2026), built from audited fundamentals. The current price: $1.95.
What is the quality score of CNTN?
Canton Strategic Holdings, Inc. has a Quality Score of 21/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Canton Strategic Holdings, Inc. (CNTN)?
Our model-based price target is the fair value of $0.4675 (as of Oct 30, 2026) from 1 valuation models. Cautious scenario $0.3910, optimistic scenario $0.5355. It is a calculation from audited fundamentals, not an analyst target.
What is the Canton Strategic Holdings, Inc. stock forecast for 2026?
Our models put fair value at $0.4675, about −76% upside versus a price of $1.95 (overvalued). Cautious scenario $0.3910, optimistic scenario $0.5355. The calculation is refreshed regularly with new filings.
What is the revenue of Canton Strategic Holdings, Inc. (CNTN)?
Canton Strategic Holdings, Inc. reported trailing-twelve-month revenue of about $1.5M (latest available figure, as of Oct 30, 2026).
What is the intrinsic value of Canton Strategic Holdings, Inc. (CNTN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Canton Strategic Holdings, Inc. it is $0.4675 per share (as of Oct 30, 2026), against a price of $1.95. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Canton Strategic Holdings, Inc. stock overvalued or undervalued in 2026?
As of Oct 30, 2026, CNTN trades above its calculated fair value: price $1.95, fair value $0.4675, a gap of about −76% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CNTN?
No. The price is what the market pays today ($1.95); the fair value is what the company's own numbers justify ($0.4675). For Canton Strategic Holdings, Inc. the two are $1.48 per share apart. That gap is exactly why we show both numbers side by side.
How much is Canton Strategic Holdings, Inc. worth?
The market values Canton Strategic Holdings, Inc. at about $163M (market capitalisation, as of Oct 30, 2026). Per share that is $1.95; our models calculate a fair value of $0.4675 per share.
What do the bullish and bearish scenarios say about CNTN?
Our models span a range for Canton Strategic Holdings, Inc.: cautious scenario $0.3910, base $0.4675, optimistic $0.5355 per share (as of Oct 30, 2026, price $1.95). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Canton Strategic Holdings, Inc. (CNTN)?
Balance-sheet figures for Canton Strategic Holdings, Inc. (as of Oct 30, 2026): return on equity −42.2%. They feed the Quality Score of 21/100, which measures business quality independently of the share price.
How far is CNTN from its 52-week high?
Canton Strategic Holdings, Inc. trades at $1.95, about 64% below its 52-week high of $5.48 and 15% above the low of $1.69 (as of Oct 30, 2026). Distance from the high says nothing about value: that is what the fair value of $0.4675 is for.
Which stocks are comparable to Canton Strategic Holdings, Inc.?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc, CSL Limited, argenx SE, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Canton Strategic Holdings, Inc. stock attractive at the current price?
The data as of Oct 30, 2026: price $1.95, calculated fair value $0.4675 (−76%), Quality Score 21/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CNTN calculated?
We run Canton Strategic Holdings, Inc. through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.4675, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. Canton Strategic Holdings, Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Canton Strategic Holdings, Inc. (CNTN)?
The closing price on Oct 30, 2026 was $1.95. Our model-based fair value is $0.4675, about −76% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Canton Strategic Holdings, Inc. right now?
The price sits above even our optimistic bull case ($0.5355). The favourable scenario is already priced in. Weak quality (21/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Canton Strategic Holdings, Inc.

How large is the market capitalisation of Canton Strategic Holdings, Inc. (CNTN)?
The market capitalisation of Canton Strategic Holdings, Inc. is $163M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Canton Strategic Holdings, Inc. (CNTN)?
Earnings per share at Canton Strategic Holdings, Inc. are $−0.1000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Canton Strategic Holdings, Inc. (CNTN)?
The return on equity (ROE) of Canton Strategic Holdings, Inc. is −42.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Canton Strategic Holdings, Inc. (CNTN)?
On an EBIT basis the return on assets of Canton Strategic Holdings, Inc. is −209% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Canton Strategic Holdings, Inc. (CNTN)?
The operating margin of Canton Strategic Holdings, Inc. is −80.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does Canton Strategic Holdings, Inc. (CNTN) generate?
The free cash flow of Canton Strategic Holdings, Inc. is −$16.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Canton Strategic Holdings, Inc. (CNTN) hold?
Canton Strategic Holdings, Inc. holds more cash than debt, $17.0M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Canton Strategic Holdings, Inc. in the live analysis

One click puts Canton Strategic Holdings, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.